Cargando…

Assessment of adherence to therapy and exploring of barriers and facilitators in HIV positive patients in Tabriz-Iran: a mixed method study protocol

BACKGROUND: Adherence to therapy is a key predictor of the success of human immunodeficiency virus (HIV) treatment. There is limited information available from Iran about that and there is a need for more knowledge about factors influencing treatment adherence. The aim of this study is to examine ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanbari, Amin, Khiaban, Maryam Ordibeheshti, Aslani, Armin, Faraji, Amir Reza, Mohammadi, Milad, Kazemi, Azita Fathnezhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637478/
https://www.ncbi.nlm.nih.gov/pubmed/31315629
http://dx.doi.org/10.1186/s12978-019-0766-x
_version_ 1783436246679289856
author Ghanbari, Amin
Khiaban, Maryam Ordibeheshti
Aslani, Armin
Faraji, Amir Reza
Mohammadi, Milad
Kazemi, Azita Fathnezhad
author_facet Ghanbari, Amin
Khiaban, Maryam Ordibeheshti
Aslani, Armin
Faraji, Amir Reza
Mohammadi, Milad
Kazemi, Azita Fathnezhad
author_sort Ghanbari, Amin
collection PubMed
description BACKGROUND: Adherence to therapy is a key predictor of the success of human immunodeficiency virus (HIV) treatment. There is limited information available from Iran about that and there is a need for more knowledge about factors influencing treatment adherence. The aim of this study is to examine adherence levels and to explore patients’ views about barriers and facilitators to HIV treatment adherence. METHODS: This mixed-method study with the sequential explanatory design has two phases. The first phase (quantitative phase) is a cross- sectional study to assess the in Tabriz, the sixth large city of Iran. A convenience sampling method will be used to select 150 HIV positive patients who visit health centers in Tabriz. The second phase is a qualitative study designed to explore the HIV positive patients’ views of barriers and facilitators that can affect their adherence to therapy. In this phase, purposive sampling and in-depth individual interviews will be conducted for data collection. The conventional content analysis approach will be employed for data analysis. In addition to literature review and nominal group technique, the findings of the qualitative and quantitative phases, will be used to recommend some strategies to support adherence to therapy in HIV positive patients. DISCUSSION: This is the first study looking into adherence to therapy and exploring of factors influencing in HIV positive patients which will be performed via a mixed-method approach, aiming to develop health practices improvement strategies. It is worth noting that there is no strategic guideline in Iran’s health system for improvement of treatment adherence in HIV positive patients. Health professionals and policy makers can be aware of factors influencing HIV treatment adherence. Therefore, it is hoped that the strategy proposed in the current study can lead to improvements their ability to treatment adherence.
format Online
Article
Text
id pubmed-6637478
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66374782019-07-25 Assessment of adherence to therapy and exploring of barriers and facilitators in HIV positive patients in Tabriz-Iran: a mixed method study protocol Ghanbari, Amin Khiaban, Maryam Ordibeheshti Aslani, Armin Faraji, Amir Reza Mohammadi, Milad Kazemi, Azita Fathnezhad Reprod Health Study Protocol BACKGROUND: Adherence to therapy is a key predictor of the success of human immunodeficiency virus (HIV) treatment. There is limited information available from Iran about that and there is a need for more knowledge about factors influencing treatment adherence. The aim of this study is to examine adherence levels and to explore patients’ views about barriers and facilitators to HIV treatment adherence. METHODS: This mixed-method study with the sequential explanatory design has two phases. The first phase (quantitative phase) is a cross- sectional study to assess the in Tabriz, the sixth large city of Iran. A convenience sampling method will be used to select 150 HIV positive patients who visit health centers in Tabriz. The second phase is a qualitative study designed to explore the HIV positive patients’ views of barriers and facilitators that can affect their adherence to therapy. In this phase, purposive sampling and in-depth individual interviews will be conducted for data collection. The conventional content analysis approach will be employed for data analysis. In addition to literature review and nominal group technique, the findings of the qualitative and quantitative phases, will be used to recommend some strategies to support adherence to therapy in HIV positive patients. DISCUSSION: This is the first study looking into adherence to therapy and exploring of factors influencing in HIV positive patients which will be performed via a mixed-method approach, aiming to develop health practices improvement strategies. It is worth noting that there is no strategic guideline in Iran’s health system for improvement of treatment adherence in HIV positive patients. Health professionals and policy makers can be aware of factors influencing HIV treatment adherence. Therefore, it is hoped that the strategy proposed in the current study can lead to improvements their ability to treatment adherence. BioMed Central 2019-07-17 /pmc/articles/PMC6637478/ /pubmed/31315629 http://dx.doi.org/10.1186/s12978-019-0766-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Ghanbari, Amin
Khiaban, Maryam Ordibeheshti
Aslani, Armin
Faraji, Amir Reza
Mohammadi, Milad
Kazemi, Azita Fathnezhad
Assessment of adherence to therapy and exploring of barriers and facilitators in HIV positive patients in Tabriz-Iran: a mixed method study protocol
title Assessment of adherence to therapy and exploring of barriers and facilitators in HIV positive patients in Tabriz-Iran: a mixed method study protocol
title_full Assessment of adherence to therapy and exploring of barriers and facilitators in HIV positive patients in Tabriz-Iran: a mixed method study protocol
title_fullStr Assessment of adherence to therapy and exploring of barriers and facilitators in HIV positive patients in Tabriz-Iran: a mixed method study protocol
title_full_unstemmed Assessment of adherence to therapy and exploring of barriers and facilitators in HIV positive patients in Tabriz-Iran: a mixed method study protocol
title_short Assessment of adherence to therapy and exploring of barriers and facilitators in HIV positive patients in Tabriz-Iran: a mixed method study protocol
title_sort assessment of adherence to therapy and exploring of barriers and facilitators in hiv positive patients in tabriz-iran: a mixed method study protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637478/
https://www.ncbi.nlm.nih.gov/pubmed/31315629
http://dx.doi.org/10.1186/s12978-019-0766-x
work_keys_str_mv AT ghanbariamin assessmentofadherencetotherapyandexploringofbarriersandfacilitatorsinhivpositivepatientsintabriziranamixedmethodstudyprotocol
AT khiabanmaryamordibeheshti assessmentofadherencetotherapyandexploringofbarriersandfacilitatorsinhivpositivepatientsintabriziranamixedmethodstudyprotocol
AT aslaniarmin assessmentofadherencetotherapyandexploringofbarriersandfacilitatorsinhivpositivepatientsintabriziranamixedmethodstudyprotocol
AT farajiamirreza assessmentofadherencetotherapyandexploringofbarriersandfacilitatorsinhivpositivepatientsintabriziranamixedmethodstudyprotocol
AT mohammadimilad assessmentofadherencetotherapyandexploringofbarriersandfacilitatorsinhivpositivepatientsintabriziranamixedmethodstudyprotocol
AT kazemiazitafathnezhad assessmentofadherencetotherapyandexploringofbarriersandfacilitatorsinhivpositivepatientsintabriziranamixedmethodstudyprotocol